Our discovery that MRP1 effluxes L-AMEND, which suppresses PMN migration, provides two potential and independent treatment strategies to reduce PMN migration and thus limit development of bacteremia: apical presentation of exogenous L-AMEND or local inhibition of MRP2. This evidence concerns the gene ABCC2 and bacterial infectious disease with sepsis.